Burstein S H, Hull K, Hunter S A, Latham V
Department of Biochemistry, University of Massachusetts Medical School, Worcester 01655.
FASEB J. 1988 Nov;2(14):3022-6. doi: 10.1096/fasebj.2.14.2846397.
The principal metabolite of delta 1-THC, delta 1-THC-7-oic acid exhibits significant analgesic action in the mouse hot plate test. The parent delta 1-THC has a similar effect when measured at later time points; however, 10 min after drug administration, a pronounced hyperalgesia is seen. This hyperalgesia can be inhibited by prior administration of either indomethacin or delta 1-THC-7-oic acid, presumably because of their ability to inhibit eicosanoid synthesis. Administration of prostaglandin E2 (PGE2), at doses that were a small fraction of the delta 1-THC given, resulted in a strong hyperalgesic response. Unlike delta 1-THC, the metabolite does not produce a cataleptic state in the mouse, which eliminates this as a basis for the hot plate response. The evidence presented is consistent with a mechanism in which the metabolite inhibits eicosanoid synthesis whereas the parent drug elevates tissue levels of prostaglandins.
δ1-四氢大麻酚的主要代谢产物δ1-四氢大麻酚-7- 羧酸在小鼠热板试验中表现出显著的镇痛作用。母体δ1-四氢大麻酚在稍后的时间点测量时具有类似的效果;然而,给药10分钟后,会出现明显的痛觉过敏。这种痛觉过敏可以通过预先给予吲哚美辛或δ1-四氢大麻酚-7- 羧酸来抑制,这可能是因为它们具有抑制类花生酸合成的能力。给予剂量仅为所给δ1-四氢大麻酚一小部分的前列腺素E2(PGE2),会导致强烈的痛觉过敏反应。与δ1-四氢大麻酚不同,该代谢产物不会在小鼠中产生僵住状态,从而排除了将其作为热板反应基础的可能性。所提供的证据与一种机制一致,即该代谢产物抑制类花生酸合成,而母体药物则提高组织中前列腺素的水平。